These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 18156463)

  • 21. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
    Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
    ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain.
    Dufes C; Gaillard F; Uchegbu IF; Schätzlein AG; Olivier JC; Muller JM
    Int J Pharm; 2004 Nov; 285(1-2):77-85. PubMed ID: 15488681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
    Pardridge WM
    Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New protein vectors for physiological transfer of therapeutic agents to the central nervous system].
    Gabathuler R
    Biol Aujourdhui; 2012; 206(3):191-203. PubMed ID: 23171842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
    J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro.
    Candela P; Gosselet F; Miller F; Buee-Scherrer V; Torpier G; Cecchelli R; Fenart L
    Endothelium; 2008; 15(5-6):254-64. PubMed ID: 19065317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and brain uptake of lactoferrin in rats.
    Ji B; Maeda J; Higuchi M; Inoue K; Akita H; Harashima H; Suhara T
    Life Sci; 2006 Jan; 78(8):851-5. PubMed ID: 16165165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.
    Tucker IG; Yang L; Mujoo H
    J Microencapsul; 2012; 29(5):475-86. PubMed ID: 22563886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.
    Alaofi A; On N; Kiptoo P; Williams TD; Miller DW; Siahaan TJ
    J Pharm Sci; 2016 Feb; 105(2):797-807. PubMed ID: 26869430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vector-mediated delivery of opioid peptides to the brain.
    Bickel U; Pardridge WM
    NIDA Res Monogr; 1995; 154():28-46. PubMed ID: 8606748
    [No Abstract]   [Full Text] [Related]  

  • 35. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
    Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
    PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.
    Re F; Cambianica I; Zona C; Sesana S; Gregori M; Rigolio R; La Ferla B; Nicotra F; Forloni G; Cagnotto A; Salmona M; Masserini M; Sancini G
    Nanomedicine; 2011 Oct; 7(5):551-9. PubMed ID: 21658472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polarized localization of amino acid/carnitine transporter B(0,+) (ATB(0,+)) in the blood-brain barrier.
    Czeredys M; Mysiorek C; Kulikova N; Samluk Ł; Berezowski V; Cecchelli R; Nałecz KA
    Biochem Biophys Res Commun; 2008 Nov; 376(2):267-70. PubMed ID: 18771654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.
    Boado RJ
    Drug News Perspect; 2008 Nov; 21(9):489-503. PubMed ID: 19180267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.